| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.075 | 0.2 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.094 | 0.2 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.2 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.097 | 0.2 |